John Wiley & Sons

SHERPA: Green

People

  1. Sadelain
    Sadelain
  2. Lesokhin
    Lesokhin
  3. Landgren
    Landgren
  4. Scheinberg
    Scheinberg
  5. Brentjens
    Brentjens
  6. Chiosis
    Chiosis
  7. Kentsis
    Kentsis
  8. Korde
    Korde
  9. Old
    Old
  10. Blum
    Blum

Groups

  1. Center for Hematologic Malignancies (45)
  2. Hematologic Malignancies Research (45)
  3. Department of Medicine (36)
  4. Hematologic Malignancies, Division of (35)
  5. GSK Faculty (33)
  6. Sloan Kettering Institute Faculty (30)
  7. Molecular Pharmacology and Chemistry Program Faculty (27)
  8. Myeloma (12)
  9. Tow Center for Developmental Oncology (TCDO) (12)
  10. Adult Leukemia (10)
Search Within
  1. "Hematologic Malignancies Research"
Formats
  1. Journal Article (26)
  2. Meeting Abstract (12)
  3. Conference Paper (3)
  4. Editorial (2)
  5. Review (2)
Groups
  1. Center for Hematologic Malignancies (45)
  2. Hematologic Malignancies Research (45)
  3. Department of Medicine (36)
  4. Hematologic Malignancies, Division of (35)
  5. GSK Faculty (33)
  6. Sloan Kettering Institute Faculty (30)

More Groups

People
  1. Michel Sadelain (13)
  2. Alexander Lesokhin (7)
  3. Carl Landgren (6)
  4. David Scheinberg (5)
  5. Gabriela Chiosis (4)
  6. Isabelle Riviere (4)

More People

Years
  1. 2024 (1)
  2. 2023 (3)
  3. 2022 (1)
  4. 2021 (4)
  5. 2020 (4)
  6. 2019 (1)

More Years

Publications
  1. British Journal of Haematology (17)
  2. Annals of the New York Academy of Sciences (6)
  3. Journal of Gene Medicine (5)
  4. American Journal of Hematology (3)
  5. Hepatology (3)
  6. International Journal of Cancer (3)

More Publications

Results (45)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Soluble B-cell maturation antigen in multiple myeloma
    Review

    Costa, B. A.; Ortiz, R. J.; Lesokhin, A. M.; Richter, J.
    American Journal of Hematology (2024)

    Fulltext@MSK | Save
  • Pooled analysis of MagnetisMM studies: Efficacy and safety of elranatamab in patients with relapsed or refractory multiple myeloma (RRMM) previously exposed to B-cell maturation antigen (BCMA)-directed therapies
    Meeting Abstract

    Nooka, A. K.; Lesokhin, A. M.; Mohty, M.; Niesvizky, R.; Maise, C.; Arnulf, A.; Larson, S. M.; Asya, V. Y. N.; Leleu, X.; Karlin, L.; more...
    American Journal of Hematology (2023)

    Fulltext@MSK | Save
  • A subgroup analysis from MagnetisMM-3: the efficacy and safety of elranatamab by age and frailty in patients with relapsed or refractory multiple myeloma
    Meeting Abstract

    Raje, N.; Leleu, X.; Lesokhin, A. M.; Mohty , M.; Nooka, A.; Leip, E.; Conte, U.; Vlqueira, A.; Manier, S.
    American Journal of Hematology (2023)

    Fulltext@MSK | Save
  • Efficacy and safety of elranatamab in patients with relapsed/refractory multiple myeloma: Cohort a of MagnetisMM-3
    Meeting Abstract

    Shay, G.; Bahlis, N.; Tomasson, M. H.; Mohty, M.; Niesvizky, R.; Nooka, A.; Manier, S.; Maisel, C.; Jethava, Y.; Martinez-Lopez, J.; more...
    British Journal of Haematology (2023)

    Fulltext@MSK | Save
  • Comparison of venous thromboembolism incidence in newly diagnosed multiple myeloma patients receiving bortezomib, lenalidomide, dexamethasone (RVD) or carfilzomib, lenalidomide, dexamethasone (KRD) with aspirin or rivaroxaban thromboprophylaxis
    Journal Article

    Piedra, K.; Peterson, T.; Tan, C.; Orozco, J.; Hultcrantz, M.; Hassoun, H.; Mailankody, S.; Lesokhin, A.; Shah, U.; Lu, S.; more...
    British Journal of Haematology (2022)

    Fulltext@MSK | Save
  • Myeloid endoplasmic reticulum resident chaperone GP96 facilitates inflammation and steatosis in alcohol-associated liver disease
    Journal Article

    Ratna, A.; Lim, A.; Li, Z.; Argemi, J.; Bataller, R.; Chiosis, G.; Mandrekar, P.
    Hepatology Communications (2021)

    Fulltext@MSK | Save
  • Metabolic decisions in development and disease—A Keystone Symposia report
    Journal Article

    Cable, J.; Pourquié, O.; Wellen, K. E.; Finley, L. W. S.; Aulehla, A.; Gould, A. P.; Teleman, A.; Tu, W. B.; Garrett, W. S.; Miguel-Aliaga, I.; more...
    Annals of the New York Academy of Sciences (2021)

    Fulltext@MSK | Save
  • CARTITUDE-1: Phase 1b/2 study of ciltacabtagene autoleucel in relapsed/refractory multiple myeloma
    Meeting Abstract

    Madduri, D.; Berdeja, J.; Usmani, S.; Jakubowiak, A.; Agha, M.; Cohen, A.; Stewart, A. K.; Hari, P.; Htut, M.; O'Donnell, E.; more...
    British Journal of Haematology (2021)

    Fulltext@MSK | Save
  • Frontiers in cancer immunotherapy - A symposium report
    Editorial

    Cable, J.; Greenbaum, B.; Pe'er, D.; Bollard, C. M.; Bruni, S.; Griffin, M. E.; Allison, J. P.; Wu, C. J.; Subudhi, S. K.; Mardis, E. R.; more...
    Annals of the New York Academy of Sciences (2021)

    Fulltext@MSK | Save
  • The role of high-dose melphalan with autologous stem-cell transplant in multiple myeloma: Is it time for a paradigm shift?
    Review

    Kazandjian, D.; Mo, C. C.; Landgren, O.; Richardson, P. G.
    British Journal of Haematology (2020)

    Fulltext@MSK | Save